ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $372,539,000 | +18.7% | 2,164,663 | -13.4% | 1.74% | +35.8% |
| Q2 2021 | $313,725,000 | -11.0% | 2,500,000 | -3.8% | 1.28% | -26.9% |
| Q1 2021 | $352,586,000 | +6.0% | 2,600,000 | 0.0% | 1.75% | -12.4% |
| Q4 2020 | $332,644,000 | +13.7% | 2,600,000 | 0.0% | 2.00% | -1.1% |
| Q3 2020 | $292,578,000 | +46.2% | 2,600,000 | +23.8% | 2.02% | +26.4% |
| Q2 2020 | $200,067,000 | +2.4% | 2,100,000 | -3.4% | 1.60% | -4.6% |
| Q1 2020 | $195,467,000 | +84.3% | 2,175,000 | +8.8% | 1.68% | +134.4% |
| Q4 2019 | $106,040,000 | +11.8% | 2,000,000 | -16.7% | 0.72% | 0.0% |
| Q3 2019 | $94,824,000 | -2.8% | 2,400,000 | +1.1% | 0.72% | +12.8% |
| Q2 2019 | $97,565,000 | -11.8% | 2,375,000 | 0.0% | 0.64% | -23.7% |
| Q1 2019 | $110,604,000 | +20.9% | 2,375,000 | +13.1% | 0.83% | +24.0% |
| Q4 2018 | $91,455,000 | -13.2% | 2,100,000 | +14.1% | 0.67% | +7.9% |
| Q3 2018 | $105,345,000 | +55.0% | 1,840,732 | +31.4% | 0.62% | +48.1% |
| Q2 2018 | $67,977,000 | +24.1% | 1,401,000 | 0.0% | 0.42% | +10.8% |
| Q1 2018 | $54,779,000 | +18.6% | 1,401,000 | +28.8% | 0.38% | +1.1% |
| Q4 2017 | $46,175,000 | +28.5% | 1,088,000 | +13.0% | 0.38% | +17.6% |
| Q3 2017 | $35,939,000 | – | 963,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |